These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28397841)

  • 1. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [
    Esterlis I; DellaGioia N; Pietrzak RH; Matuskey D; Nabulsi N; Abdallah CG; Yang J; Pittenger C; Sanacora G; Krystal JH; Parsey RV; Carson RE; DeLorenzo C
    Mol Psychiatry; 2018 Apr; 23(4):824-832. PubMed ID: 28397841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
    DeLorenzo C; DellaGioia N; Bloch M; Sanacora G; Nabulsi N; Abdallah C; Yang J; Wen R; Mann JJ; Krystal JH; Parsey RV; Carson RE; Esterlis I
    Biol Psychiatry; 2015 Feb; 77(3):266-275. PubMed ID: 25156701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.
    Esterlis I; Holmes SE; Sharma P; Krystal JH; DeLorenzo C
    Biol Psychiatry; 2018 Jul; 84(2):95-105. PubMed ID: 29100629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
    DeLorenzo C; Sovago J; Gardus J; Xu J; Yang J; Behrje R; Kumar JS; Devanand DP; Pelton GH; Mathis CA; Mason NS; Gomez-Mancilla B; Aizenstein H; Mann JJ; Parsey RV
    Transl Psychiatry; 2015 Dec; 5(12):e693. PubMed ID: 26645628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Ketamine Infusion in Rat Does Not Affect In Vivo [
    Kosten L; Verhaeghe J; Wyffels L; Stroobants S; Staelens S
    Mol Imaging; 2018; 17():1536012118788636. PubMed ID: 30213221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression.
    Kim JH; Joo YH; Son YD; Kim JH; Kim YK; Kim HK; Lee SY; Ido T
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):278-290. PubMed ID: 30553696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.
    Martinez D; Slifstein M; Nabulsi N; Grassetti A; Urban NB; Perez A; Liu F; Lin SF; Ropchan J; Mao X; Kegeles LS; Shungu DC; Carson RE; Huang Y
    Biol Psychiatry; 2014 Jan; 75(2):165-71. PubMed ID: 24035345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest variability of [
    Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
    Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [
    Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH
    Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep.
    Hefti K; Holst SC; Sovago J; Bachmann V; Buck A; Ametamey SM; Scheidegger M; Berthold T; Gomez-Mancilla B; Seifritz E; Landolt HP
    Biol Psychiatry; 2013 Jan; 73(2):161-8. PubMed ID: 22959709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
    Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.
    Nugent AC; Robinson SE; Coppola R; Zarate CA
    Psychiatry Res Neuroimaging; 2016 Aug; 254():56-66. PubMed ID: 27362845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Characterization of mGluR5 Using
    Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7T
    Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
    Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
    Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
    Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.